Metabolic Diseases

Interconnected cardio-renal-metabolic conditions – affecting the heart, kidneys, and metabolic system – are the leading cause of mortality worldwide and account for up to 20 million deaths annually. 

Building on our expertise in developing innovative treatments for a range of cardiovascular and metabolic conditions, our R&D strategy in cardiometabolic diseases takes a holistic view on the therapeutic needs of people affected by multiple, related cardiovascular and metabolic conditions.